PROCEEDINGS OF A SYMPOSIUM AT THE CANADIAN ASSOCIATION OF POPULATION THERAPEUTICS 2010 ANNUAL MEETING "ASSESSING THE VALUE OF NEW THERAPIES: WHERE DO WE GO FROM HERE?"

Main Article Content

Scott Gavura
Cancer Care Ontario

Mona Sabharwal
Formerly, Ontario Public Drug Programs

Amir Attaran
University of Ottawa

Jens Grueger
Pfizer Inc.

Durhane Wong-Rieger
Consumer Advocate Network

Margaret Somerville
McGill University

Angela Rocchi
Axia Research Inc.

Keywords

.

Abstract

INTRODUCTION


Payer Perspective


Legal Perspective


Industry Perspective


Patient Perspective


Embedding Ethics in HTA and Allocation of Healthcare Resource Decisions


SUMMARY

Abstract 166 | PDF Downloads 105

References

.

Article Sidebar

PDF
Published
Dec 2, 2018

Article Details

How to Cite
Gavura, S., Sabharwal, M., Attaran, A., Grueger, J., Wong-Rieger, D., Somerville, M., & Rocchi, A. (2018). PROCEEDINGS OF A SYMPOSIUM AT THE CANADIAN ASSOCIATION OF POPULATION THERAPEUTICS 2010 ANNUAL MEETING "ASSESSING THE VALUE OF NEW THERAPIES: WHERE DO WE GO FROM HERE?". Journal of Population Therapeutics and Clinical Pharmacology, 18(2). https://mail.jptcp.com/index.php/jptcp/article/view/472
Issue
Vol. 18 No. 2 (2011)
Section
Articles

All articles published in JPTCP  are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Gavura, S., Sabharwal, M., Attaran, A., Grueger, J., Wong-Rieger, D., Somerville, M., & Rocchi, A. (2018). PROCEEDINGS OF A SYMPOSIUM AT THE CANADIAN ASSOCIATION OF POPULATION THERAPEUTICS 2010 ANNUAL MEETING "ASSESSING THE VALUE OF NEW THERAPIES: WHERE DO WE GO FROM HERE?". Journal of Population Therapeutics and Clinical Pharmacology, 18(2). https://mail.jptcp.com/index.php/jptcp/article/view/472